MC1R and Parkinson disease: Participants with MC1R PD (n=220) had a higher rate of change in MDS-UPDRS III than those with sporadic PD (2.44; β diff=0.46 (0.03 to 0.88) p=0.035)(Figure 1 and Table 3).